Diabetic Macular Edema (DME) Completed Phase 1 Trials for Teprotumumab (DB06343)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02103283A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)Treatment